Ledger.Open graph →

SEC Form D · filed June 12, 2020

GT Biopharma, Inc

Offering

—

Sold

$2.4M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

Beverly Hills, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Anthony Cataldo · Beverly Hills, CAExec · Director Steven Weldon · Las Vegas, NVExec · Director Anthony Cataldo · Los Angeles, CAExec · Director Steven Weldon · Washington, Washington, D.C.Exec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗